Ozanne EM - Search Results

1

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.

Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Lowry KP, et al. Among authors: ozanne em. Cancer. 2012 Apr 15;118(8):2021-30. doi: 10.1002/cncr.26424. Epub 2011 Sep 20. Cancer. 2012. PMID: 21935911 Free PMC article.

2

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.

Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Lee JM, et al. Among authors: ozanne em. Radiology. 2010 Mar;254(3):793-800. doi: 10.1148/radiol.09091086. Radiology. 2010. PMID: 20177093 Free PMC article.

3

Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis.

Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS. Pandharipande PV, et al. Among authors: ozanne em. AJR Am J Roentgenol. 2008 Nov;191(5):1308-19. doi: 10.2214/AJR.07.3861. AJR Am J Roentgenol. 2008. PMID: 18941062

4

Patient preferences for the chemoprevention of colorectal cancer.

Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Hur C, et al. Among authors: ozanne em. Dig Dis Sci. 2009 Oct;54(10):2207-14. doi: 10.1007/s10620-008-0609-z. Epub 2008 Dec 5. Dig Dis Sci. 2009. PMID: 19057995 Free PMC article.

5

Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus.

Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Hur C, et al. Am J Gastroenterol. 2008 Oct;103(10):2432-42. doi: 10.1111/j.1572-0241.2008.02117.x. Epub 2008 Sep 4. Am J Gastroenterol. 2008. PMID: 18775019 Free PMC article.

6

Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis.

Ozanne EM, Esserman LJ. Ozanne EM, et al. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2043-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598759

7

What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.

Durand MA, Yen RW, O'Malley AJ, Schubbe D, Politi MC, Saunders CH, Dhage S, Rosenkranz K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Walling L, Marx CM, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Bergin E, Goodwin C, Miller C, Harris C, Barth RJ Jr, Aft R, Feldman S, Cyr AE, Angeles CV, Jiang S, Elwyn G. Durand MA, et al. Cancer. 2021 Feb 1;127(3):422-436. doi: 10.1002/cncr.33248. Epub 2020 Nov 10. Cancer. 2021. PMID: 33170506 Free PMC article. Clinical Trial.

8

Characterizing the impact of 25 years of DCIS treatment.

Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Ozanne EM, et al. Breast Cancer Res Treat. 2011 Aug;129(1):165-73. doi: 10.1007/s10549-011-1430-5. Epub 2011 Mar 9. Breast Cancer Res Treat. 2011. PMID: 21390494

9

Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.

Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Soeteman DI, et al. Among authors: ozanne em. J Natl Cancer Inst. 2013 Jun 5;105(11):774-81. doi: 10.1093/jnci/djt096. Epub 2013 May 3. J Natl Cancer Inst. 2013. PMID: 23644480 Free PMC article.

10

Which risk model to use? Clinical implications of the ACS MRI screening guidelines.

Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS. Ozanne EM, et al. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):146-9. doi: 10.1158/1055-9965.EPI-12-0570. Epub 2012 Oct 23. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23093547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page